(Q34669824)

3 August 2017

title

Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience (English)

1 reference

3 August 2017

4

Edward Romond

0 references

author name string

Soonmyung Paik

1

1 reference

3 August 2017

John Bryant

2

1 reference

3 August 2017

Elizabeth Tan-Chiu

3

1 reference

3 August 2017

William Hiller

5

1 reference

3 August 2017

Kyeongmee Park

6

1 reference

3 August 2017

Ann Brown

7

1 reference

3 August 2017

Greg Yothers

8

1 reference

3 August 2017

Steve Anderson

9

1 reference

3 August 2017

Roy Smith

10

1 reference

3 August 2017

D Lawrence Wickerham

11

1 reference

3 August 2017

Norman Wolmark

12

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

Journal of the National Cancer Institute

3 August 2017

published in

1 reference

3 August 2017

volume

94

1 reference

3 August 2017

issue

11

1 reference

3 August 2017

page(s)

852-854

1 reference

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.11.852

HER2--a discussion of testing approaches in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.11.852

Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.11.852

Comparative methodological analysis of erbB-2/HER-2 gene dosage, chromosomal copy number and protein overexpression in breast carcinoma tissues for diagnostic use

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.11.852

Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.11.852

HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.11.852

Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.11.852

HER-2/neu testing in breast carcinoma: a combined immunohistochemical and fluorescence in situ hybridization approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.11.852

Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.11.852

Functional Fas-ligand expression on T cells from HIV-1-infected patients is unrelated to CD4+ lymphopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.11.852

21 January 2018

Identifiers

DOI

10.1093/JNCI/94.11.852

1 reference

3 August 2017

1 reference